Antibacterial Wipes Recalled for Improper Storage Conditions
Family Dollar Stores recalls Disney Licensed Anti Bac Wipes and Antibacterial Wipes due to storage temperature deviations. The products were distributed nationwide to Family Dollar stores from April 30 through June 10, 2022.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II FDA recall with no reported illnesses or injuries documented in the available source material. The hazard—improper storage temperature conditions—represents a potential precautionary issue rather than demonstrated safety harm. Per the severity rubric, Class II recalls without reported incidents are classified as Moderate.
Plain-English summary
Family Dollar Stores, LLC is recalling Disney Licensed Anti Bac Wipes (SKU 998908, 20 count) and Antibacterial Wipes (SKU 2007538, 40 count).
The products were distributed to Family Dollar stores nationwide between April 30, 2022 and June 10, 2022.
The recall was issued because these products were held outside appropriate storage temperature conditions, which constitutes a Current Good Manufacturing Practice (CGMP) deviation. This storage deviation may affect product quality and efficacy.
The recalled product
- Product
- DISNEY LICENSED ANTI BAC WIPES 20 CT SKU 998908; ANTIBACTERIAL WIPES 40CT SKU 2007538 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Antimicrobial Wipes
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- SKUs: 998908
- 2007538
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27